rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-2-3
|
pubmed:abstractText |
The aim of this study was to determine in a randomised trial whether there is any significant difference in toxicity between modified CHOP and MCOP chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma (NHL) and to determine whether this reduced dose chemotherapy can be administered with full dose intensity, low toxicity and produce acceptable survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0923-7534
|
pubmed:author |
pubmed-author:BessellE MEM,
pubmed-author:BurtonAA,
pubmed-author:Central Lymphoma Group UK,
pubmed-author:ChildJ AJA,
pubmed-author:CullenM HMH,
pubmed-author:DaviesJ MJM,
pubmed-author:EllisI OIO,
pubmed-author:GlaholmJJ,
pubmed-author:HaynesA PAP,
pubmed-author:JackAA,
pubmed-author:JonesE LEL,
pubmed-author:SmithG MGM
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
258-67
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12562653-Administration, Oral,
pubmed-meshheading:12562653-Age Factors,
pubmed-meshheading:12562653-Aged,
pubmed-meshheading:12562653-Aged, 80 and over,
pubmed-meshheading:12562653-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12562653-Combined Modality Therapy,
pubmed-meshheading:12562653-Cyclophosphamide,
pubmed-meshheading:12562653-Dose-Response Relationship, Drug,
pubmed-meshheading:12562653-Doxorubicin,
pubmed-meshheading:12562653-Female,
pubmed-meshheading:12562653-Humans,
pubmed-meshheading:12562653-Infusions, Intravenous,
pubmed-meshheading:12562653-Lymphoma, Non-Hodgkin,
pubmed-meshheading:12562653-Male,
pubmed-meshheading:12562653-Mitoxantrone,
pubmed-meshheading:12562653-Prednisolone,
pubmed-meshheading:12562653-Prednisone,
pubmed-meshheading:12562653-Survival,
pubmed-meshheading:12562653-Treatment Outcome,
pubmed-meshheading:12562653-Vincristine
|
pubmed:year |
2003
|
pubmed:articleTitle |
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.
|
pubmed:affiliation |
Department of Clinical Oncology, Nottingham City Hospital, Nottingham, UK. ebessell@ncht.trent.nhs.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|